相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Adenoma granulation pattern correlates with clinical variables and effect of somatostatin analogue treatment in a large series of patients with acromegaly
Stine Lyngvi Fougner et al.
CLINICAL ENDOCRINOLOGY (2012)
Six-month preoperative octreotide treatment in unselected, de novo patients with acromegaly: effect on biochemistry, tumour volume, and postoperative cure
Sven M. Carlsen et al.
CLINICAL ENDOCRINOLOGY (2011)
Resistance to Somatostatin Analogs in Acromegaly
Annamaria Colao et al.
ENDOCRINE REVIEWS (2011)
Clinically silent somatotroph adenomas are common
Alisha N. Wade et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2011)
Preoperative lanreotide treatment in acromegalic patients with macroadenomas increases short-term postoperative cure rates: a prospective, randomised trial
Zhi-gang Mao et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2010)
Relationship between cytokeratin staining patterns and clinico-pathological features in somatotropinomae
Yuriz Bakhtiar et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2010)
Incidence of Pituitary Adenomas in Northern Finland in 1992-2007
Antti Raappana et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Magnetic Resonance Imaging as a Predictor of Response to Somatostatin Analogs in Acromegaly after Surgical Failure
Manel Puig-Domingo et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Octreotide LAR vs. surgery in newly diagnosed patients with acromegaly: a randomized, open-label, multicentre study
Annamaria Colao et al.
CLINICAL ENDOCRINOLOGY (2009)
New directions in pharmacological treatment of acromegaly
Jens Bollerslev et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2009)
Guidelines for Acromegaly Management: An Update
S. Melmed et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Clinicopathological features of growth hormone-producing pituitary adenomas: Difference among various types defined by cytokeratin distribution pattern including a transitional form
Abdulkader Obari et al.
ENDOCRINE PATHOLOGY (2008)
A short acute octreotide test for response prediction of long-term treatment with somatostatin analogues in acromegalic patients
I. Halperin et al.
HORMONE AND METABOLIC RESEARCH (2008)
Preoperative octreotide treatment in newly diagnosed acromegalic patients with macroadenomas increases cure short-term postoperative rates: A prospective, randomized trial
Sven M. Carlsen et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
The clinical response to somatostatin analogues in acromegaly correlates to the somatostatin receptor subtype 2a protein expression of the adenoma
Stine L. Fougner et al.
CLINICAL ENDOCRINOLOGY (2008)
Partial surgical removal of growth hormone-secreting pituitary tumors enhances the response to somatostatin analogs in acromegaly
A Colao et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Pathology of acromegaly
Eva Horvath et al.
NEUROENDOCRINOLOGY (2006)
The implication of somatotroph adenoma phenotype to somatostatin analog responsiveness in acromegaly
S Bhayana et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Limited predictive value of an acute test with subcutaneous octreotide for long-term IGF-I normalization with Sandostatin LAR in acromegaly
WW de Herder et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2005)
The nadir growth hormone after an octreotide test dose predicts the long-term efficacy of somatostatin analogue therapy in acromegaly
JA Gilbert et al.
CLINICAL ENDOCRINOLOGY (2005)
Magnetic resonance imaging of pituitary adenomas
JF Bonneville et al.
EUROPEAN RADIOLOGY (2005)
Comparison of growth hormone-producing and non-growth hormone-producing pituitary adenomas: Imaging characteristics and pathologic correlation
A Hagiwara et al.
RADIOLOGY (2003)
Primary lymphoma of the central nervous system: Typical and atypical CT and MR imaging appearances
N Erdag et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2001)